/C O R R E C T I O N -- SuperGen, Inc.; MGI PHARMA, INC./ In the news release, SuperGen and MGI PHARMA Announce Filing of MAA for Approval of Dacogen(TM) in Europe, issued earlier today by SuperGen, Inc. and MGI PHARMA, INC. over PR Newswire, we are advised by a representative of the companies that the headline should read "SuperGen and MGI PHARMA Announce Submission of MAA for Approval of Dacogen(TM) in Europe" rather than "SuperGen and MGI PHARMA Announce Filing of MAA for Approval of Dacogen(TM) in Europe" as originally issued inadvertently. PRNewswire -- Oct. 1 DATASOURCE: SuperGen, Inc.; MGI PHARMA, INC.

Copyright